Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

SITC 2023

01–05 November 2023 | San Diego, CA

SITC 2023

01–05 November 2023 | San Diego, CA
PERIO: novel SD-101 treatment of uveal melanoma 3:45
PERIO: novel SD-101 treatment of uveal melanoma
Diwakar Davar • 2 Nov 2023
Novel delivery of TLR7/8 agonists for treatment of metastatic solid tumors 4:26
Novel delivery of TLR7/8 agonists for treatment of metastatic solid tumors
Diwakar Davar • 2 Nov 2023
Tumor phenotype associated with patient survival in a pan-cancer prospective study 3:59
Tumor phenotype associated with patient survival in a pan-cancer prospective study
João Alessi • 1 Nov 2023
How can tumor alterations determine treatment approaches in cancer? 0:58
How can tumor alterations determine treatment approaches in cancer?
João Alessi • 1 Nov 2023
Tumor microenvironment research at SITC 2023 0:48
Tumor microenvironment research at SITC 2023
João Alessi • 1 Nov 2023
Decoding sip-T’s specificity of action and efficacy with IL-15 7:17
Decoding sip-T’s specificity of action and efficacy with IL-15
Russell Pachynski • 6 Nov 2023
Sip-T treatment for metastatic castration-resistant prostate cancer 2:16
Sip-T treatment for metastatic castration-resistant prostate cancer
Russell Pachynski • 6 Nov 2023
AMBER: anti-TIM3 antibody reverses T-cell exhaustion in NSCLC 4:44
AMBER: anti-TIM3 antibody reverses T-cell exhaustion in NSCLC
Diwakar Davar • 2 Nov 2023
Modified HSV1 for skin cancer treatment 5:57
Modified HSV1 for skin cancer treatment
Diwakar Davar • 2 Nov 2023
The role of glycoproteomics in cancer progression 0:55
The role of glycoproteomics in cancer progression
Yana Najjar • 6 Nov 2023
Glycosylated proteins are predictive of immunotherapy response in metastatic melanoma 6:05
Glycosylated proteins are predictive of immunotherapy response in metastatic melanoma
Yana Najjar • 6 Nov 2023
Next steps in validating glycosylated proteins as biomarkers for melanoma treatment response 2:13
Next steps in validating glycosylated proteins as biomarkers for melanoma treatment response
Yana Najjar • 6 Nov 2023
Upcoming advancements in cellular therapies for prostate cancer 2:34
Upcoming advancements in cellular therapies for prostate cancer
Russell Pachynski • 6 Nov 2023
Advances in immunotherapy for prostate cancer at SITC 2023 2:09
Advances in immunotherapy for prostate cancer at SITC 2023
Russell Pachynski • 6 Nov 2023
NLRP3 inhibitors for tumor-driven inflammatory colitis 5:14
NLRP3 inhibitors for tumor-driven inflammatory colitis
Brent Hanks • 30 Oct 2023
Targeting myeloid cells in the future of immuno-oncology 1:25
Targeting myeloid cells in the future of immuno-oncology
Brent Hanks • 30 Oct 2023
The content of VJOncology is intended for healthcare professionals